Is D-dimer (D-dimer) elevated in End-Stage Renal Disease (ESRD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

D-dimer levels are often elevated in patients with end-stage renal disease (ESRD) due to impaired clearance by the kidneys. This elevation reduces the diagnostic utility of D-dimer for conditions like venous thromboembolism (VTE) in ESRD patients. The study by 1 highlights the challenges of interpreting biomarker elevations in patients with chronic diseases, including CKD and ESRD, where background concentrations of biomarkers like hs-cTn can be elevated, making diagnosis of acute conditions more complex.

Key Considerations

  • ESRD patients have high mortality rates, with cardiovascular disease being the predominant cause of death, accounting for 43% of all-cause mortality 1.
  • The interpretation of elevations of biomarkers like hs-cTnI or T can be difficult in patients with CKD or ESRD, as concentrations are frequently above the 99th percentile value in the absence of acute myocardial infarction (AMI) 1.
  • The diagnosis of conditions like AMI requires a characteristic rise or fall on serial sampling, not a single value above the 99th percentile, emphasizing the need for careful interpretation in clinical context 1.

Clinical Implications

  • Clinicians should exercise caution when interpreting D-dimer levels in ESRD patients and consider using higher cutoff values or relying more heavily on other diagnostic methods like imaging studies.
  • The clinical presentation should be considered alongside D-dimer results, and definitive imaging studies should be proceeded with when appropriate, rather than ruling out thrombosis based solely on D-dimer levels.
  • The study by 1 does not directly address D-dimer elevations in ESRD but highlights the complexities of biomarker interpretation in chronic diseases, underscoring the need for a nuanced approach to diagnosis in these patients.

From the Research

D-Dimer Levels in ESRD Patients

  • D-dimer levels are often elevated in patients with end-stage renal disease (ESRD) 2.
  • A study found that 75% of chronic hemodialysis patients had positive D-dimer levels (>500 μg/L), with a median D-dimer level of 966 μg/L 3.
  • Even in hemodialysis patients without additional disease, 52% had positive D-dimer levels, with a median D-dimer level of 538.5 μg/L 3.

Factors Associated with Elevated D-Dimer Levels

  • Age, C-reactive protein (CRP), recent acute illness, vascular access, anticoagulation type, and chronic diseases are associated with increased D-dimer levels 3.
  • Multivariate logistic regression analysis found that age >65 years, catheter use, and positive CRP were independently associated with positive D-dimer levels 3.

Diagnostic Accuracy of D-Dimer in ESRD Patients

  • The diagnostic accuracy of D-dimer to rule out pulmonary embolism in patients with renal insufficiency is unclear 2.
  • D-dimer levels were elevated in patients with an estimated glomerular filtration rate (eGFR) <60 mL/min, but proved to be highly sensitive for the exclusion of pulmonary embolism 2.
  • However, the specificity of D-dimer decreased significantly with impaired renal function, and almost all patients with impaired renal function had elevated D-dimer levels irrespective of the presence of pulmonary embolism 2.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

D-dimer to rule out pulmonary embolism in renal insufficiency.

The American journal of medicine, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.